. Author manuscript; available in PMC: 2009 Jul 4.

Published in final edited form as: Vaccine. 2008 May 20;26(29-30):3587–3593. doi: 10.1016/j.vaccine.2008.04.079

Table 1.

Competitive inhibition ELISA. Plates were coated with B. bronchiseptica 10580, Rb50 or B. parapertussis 15989 LPS at 5 ug/ml and reacted with anti-B. bronchiseptica 10580, anti-Rb50 or anti-B. parapertussis 15989 hyperimmune mice sera. Inhibitors were used at 50 ug/well.

Inhibitor	O-SP end-group	Amidation of 2^nd O-SP sugar	% of inhibition of hyperimmune whole cell sera
Inhibitor	O-SP end-group	Amidation of 2^nd O-SP sugar	anti-Bb10580	anti-BbRb50	anti-Bpp15989
Bb 10580 O-SP	Ala	−	92	2	50
Bb 110H O-SP	Ala	−	96	3	45
Bb Rb50 O-SP	Lac	−	0	93	1
Bb 512 O-SP	Lac	−	1	95	3
Bpp 15989 O-SP	Ala	+	42	5	97
Bpp 15311 O-SP	Ala	+	50	3	98
H. ducreyi O-SP	na¹	na	0	0	0

na - not applicable